Peppermint VenturePartners

Overview

Peppermint VenturePartners (PVP) is a private venture capital firm based in Berlin, Germany, specializing in early-stage investments in the healthcare sector. The firm focuses on supporting innovative companies in medical devices, digital health, and platform technologies across Europe. PVP aims to match excellence in technology with excellence in business execution, unlocking market potential and accelerating growth for technology-driven early-stage companies in the life science tools and services space. The firm's values include integrity, fairness, commitment, teamwork, diversity, and adherence to ESG principles, which guide their investment decisions. PVP's investment strategy involves collaborating closely with dedicated founders and management teams, providing them with unique experience and a strong network of relevant stakeholders in the life science sector. The firm has established longstanding relationships with leading research centers in Germany, such as the Charité and the Helmholtz Association, to support the validation and translation of disruptive scientific ideas into medical solutions. PVP's team members are deeply embedded as judges, mentors, and coaches in various international start-up initiatives, business plan competitions, and funding networks like TechTour, EIT Health, and EIC. The firm's track record includes managing the Charité Biomedical Fund (CBF), which invests in young companies in the healthcare sector that have demonstrated first proof-of-concept for their technology, product, or services. PVP also manages the Helmholtz Validation Fund (HVF), which funds internal projects bridging the gap between research results and their marketable applications. PVP's team members have a combined experience of over 100 years in venture capital and industry expertise, with a ratio of 21 investments to 14 exits, and currently have six active portfolio companies. PVP's approach is to work collaboratively with dedicated founders and management teams, supporting them with their unique experience and strong network of relevant stakeholders in the life science sector. The firm has established longstanding relationships with leading research centers in Germany, such as the Charité and the Helmholtz Association, to support the validation and translation of disruptive scientific ideas into medical solutions. PVP's team members are deeply embedded as judges, mentors, and coaches in various international start-up initiatives, business plan competitions, and funding networks like TechTour, EIT Health, and EIC. The firm's track record includes managing the Charité Biomedical Fund (CBF), which invests in young companies in the healthcare sector that have demonstrated first proof-of-concept for their technology, product, or services. PVP also manages the Helmholtz Validation Fund (HVF), which funds internal projects bridging the gap between research results and their marketable applications. PVP's team members have a combined experience of over 100 years in venture capital and industry expertise, with a ratio of 21 investments to 14 exits, and currently have six active portfolio companies.

Investment Focus

• Technology-driven early-stage companies in the life science tools and services space with market traction and initial revenues.

Portfolio Companies